MX2018003552A - Espuma quimica sin enjuague que comprende ivermectina. - Google Patents

Espuma quimica sin enjuague que comprende ivermectina.

Info

Publication number
MX2018003552A
MX2018003552A MX2018003552A MX2018003552A MX2018003552A MX 2018003552 A MX2018003552 A MX 2018003552A MX 2018003552 A MX2018003552 A MX 2018003552A MX 2018003552 A MX2018003552 A MX 2018003552A MX 2018003552 A MX2018003552 A MX 2018003552A
Authority
MX
Mexico
Prior art keywords
ivermectin
composition
chemical foam
rinse chemical
gas
Prior art date
Application number
MX2018003552A
Other languages
English (en)
Inventor
Christophe BUGE Jean-
NADAUFOURCADE Karine
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2018003552A publication Critical patent/MX2018003552A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/122Foams; Dry foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición autoespumante que contiene ivermectina, destinada a una aplicación tópica sin enjuague destinada a ser aplicada a la piel, que comprende: al menos una composición intermediaria B que comprende un agente generador de gas, al menos una composición intermedia A que comprende un agente activador para el agente generador de gas, y la ivermectina contenida en la composición intermediaria A, en la composición intermediaria B o simultáneamente en las dos composiciones A y B. La presente invención también se refiere a un kit o un recipiente único que contiene múltiples compartimentos que contienen tal composición.
MX2018003552A 2015-09-29 2016-09-27 Espuma quimica sin enjuague que comprende ivermectina. MX2018003552A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1559206A FR3041541B1 (fr) 2015-09-29 2015-09-29 Mousse chimique non rincee comprenant de l'ivermectine
PCT/EP2016/073013 WO2017055296A1 (fr) 2015-09-29 2016-09-27 Mousse chimique non rincée comprenant de l'ivermectine

Publications (1)

Publication Number Publication Date
MX2018003552A true MX2018003552A (es) 2018-06-18

Family

ID=54783818

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018003552A MX2018003552A (es) 2015-09-29 2016-09-27 Espuma quimica sin enjuague que comprende ivermectina.

Country Status (9)

Country Link
US (1) US10987307B2 (es)
EP (1) EP3355867B1 (es)
JP (1) JP2018529723A (es)
KR (1) KR20180059532A (es)
CN (1) CN108289852A (es)
AU (1) AU2016330789B2 (es)
FR (1) FR3041541B1 (es)
MX (1) MX2018003552A (es)
WO (1) WO2017055296A1 (es)

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6689339B1 (en) 1997-11-07 2004-02-10 Medion Research Laboratories Inc. Viscous compositions containing carbon dioxide
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US5952372A (en) 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6177092B1 (en) * 1998-11-10 2001-01-23 Color Access, Inc. Self-foaming cleansing systems
US6133310A (en) 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6399652B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
FR2830415B1 (fr) 2001-10-09 2004-07-09 Rhodia Chimie Sa Utilisation d'une composition a base de gomme xanthane en tant que stabilisant de mousses molles, et les mousses a base de cette composition
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
AR042906A1 (es) 2003-01-24 2005-07-06 Connetics Australia Pty Ltd Espuma de fosfato de clindamicina sensible a la temperatura y metodo de tratamiento de acne que la utiliza
FR2854074B1 (fr) * 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
EP1642584A1 (en) * 2003-06-25 2006-04-05 Cardiovascular Institute, Ltd External preparation for improving coital function
US20050123487A1 (en) 2003-12-08 2005-06-09 Spadini Alessandro L. Stable nonaqueous liquid reactive skin care and cleansing packaged product
US20060057075A1 (en) 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
WO2006035320A2 (en) 2004-09-27 2006-04-06 Jan De Rijk Methods and compositions for treatment of water
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Res Australia Pty Ltd gel de suspensão espumante
FR2917976B1 (fr) * 2007-06-29 2010-05-28 Galderma Sa Composition dermatologique comprenant des vehicules lipidiques de calcitriol, son procede de preparation et son utilisation
EP2185637B1 (en) 2007-09-19 2013-04-03 SurModics, Inc. Biocompatible foams, systems, and methods
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
FR2924944A1 (fr) * 2007-12-18 2009-06-19 Galderma Sa Composition a base d'une avermectine et du soufre ou d'un derive du soufre, notamment pour le traitement de la rosacee
US10589134B2 (en) 2008-01-30 2020-03-17 Kimberly-Clark Worldwide, Inc. Hand health and hygiene system for hand health and infection control
DE102008029357A1 (de) 2008-06-20 2009-12-24 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Schäumende kosmetische Zubereitung
WO2010086725A1 (en) * 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Compositions for nail and skin treatment
FR2943914A1 (fr) 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
EP2429503A1 (en) 2009-05-13 2012-03-21 Protein Delivery Solutions, LLC Pharmaceutical system for trans-membrane delivery
US8637569B2 (en) * 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
FR2952815B1 (fr) * 2009-11-25 2012-01-06 Oreal Produit cosmetique
US20110236503A1 (en) 2010-03-23 2011-09-29 Cosmalabs International, Llc Topical Skincare Composition
ES2585847T3 (es) 2010-06-30 2016-10-10 Galderma Research & Development Utilización de un agonista del receptor adrenérgico alfa para prevenir o tratar un tumor de la piel
KR101729100B1 (ko) * 2010-09-24 2017-04-21 다이도 케미칼 가부시키가이샤 발포형 피부 외용제
FR2969492B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
FR2969493B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo
FR2969491B1 (fr) 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
US9301935B2 (en) 2013-06-10 2016-04-05 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
US20160120803A1 (en) 2013-06-17 2016-05-05 Contract Pharmaceuticals Limited Non-aerosol foams for topical administration
AU2014359195B2 (en) 2013-12-04 2020-02-27 Galderma Research & Development Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics
RU2016142218A (ru) 2014-03-28 2018-05-04 Галдерма Ресерч Энд Девелопмент Смываемая химическая пленка, содержащая пероксид бензоила
AU2015238224B2 (en) 2014-03-28 2020-05-14 Galderma Research & Development Non-rinse chemical mousse containing benzoyl peroxide
CN104382863B (zh) * 2014-11-29 2017-07-07 河南后羿实业集团有限公司 一种禽用伊维菌素泡腾颗粒
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.

Also Published As

Publication number Publication date
EP3355867B1 (fr) 2020-03-18
AU2016330789A1 (en) 2018-04-26
US20190192433A1 (en) 2019-06-27
CN108289852A (zh) 2018-07-17
WO2017055296A1 (fr) 2017-04-06
FR3041541B1 (fr) 2018-11-30
JP2018529723A (ja) 2018-10-11
US10987307B2 (en) 2021-04-27
KR20180059532A (ko) 2018-06-04
AU2016330789B2 (en) 2022-04-07
EP3355867A1 (fr) 2018-08-08
FR3041541A1 (fr) 2017-03-31

Similar Documents

Publication Publication Date Title
MX2018003551A (es) Composicion limpiadora auto-espumante para enjuagar que contiene ivermectina.
MX2016012360A (es) Espuma quimica sin enjuague que comprende peroxido de benzoilo.
MX2016012363A (es) Espuma quimica que se remueve con enjuague que contiene peroxido de benzoilo.
DOP2017000109A (es) Derivados de feniltriazol sustituido con hidroxialquilo y sus usos
MX2017004896A (es) Uso de hexadeca-8, 15-dienal como producto quimico aromatico.
PH12020500033A1 (en) Macrocyclic compounds and uses thereof
MX2018003643A (es) Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento del acne.
WO2015002724A3 (en) SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
PH12016500933A1 (en) Novel combination treatment for acute myeloid leukemia (aml)
MX2018003642A (es) Espuma quimica sin enjuage que contiene propionato de clobetasol y su uso en el tratamiento de la psoriasis.
MX2018003640A (es) Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis.
MX2015003901A (es) Formulaciones espumantes de cuidado de la piel.
MX371537B (es) Espuma cosmetica de una emulsion que contiene sulfato de cetearilo de sodio y monoestearato de glicerilo.
MX2017007450A (es) Composiciones fertilizantes de urea que comprenden cascaras de arroz y metodos de uso.
ZA201703199B (en) Lentil-derived foaming agent and foamable compositions containing such foaming agent
MX2018007051A (es) Sistema de blanqueamiento de multiples componentes.
MY187554A (en) Applicator having improved contents transfer ability
MX2018003647A (es) Espuma quimica sin enjuague que contiene brimonidina y su uso en el tratamiento de la rosacea.
MX2016012366A (es) Espuma quimica sin enjuague que contiene adapaleno y peroxido de benzoilo.
EP3694629A4 (en) COMPOSITION OF UREA FOR USE IN THE PRODUCTION OF Lye
MX2018003549A (es) Composicion limpiadora auto-espumante que contiene propionato de clobetasol y su uso en el tratamiento de la psoriaris.
MX2018014790A (es) Formulacion combinada de tres compuestos antivirales.
GB2564990A8 (en) Topical compositions for neuropathic pain
MX2018003552A (es) Espuma quimica sin enjuague que comprende ivermectina.
MA40027A (fr) Composition pharmaceutique comprenant un bêta-2 agoniste et un agent anticholinergique